HHS/NCATS Logo

TRANSLATOR TIDBIT 01

The Vision of Translator

As the pace of scientific research continues to advance, the problem researchers face now is not a lack of information, but pairing the right data with the right question. The vision of Translator is to help researchers more easily see connections across those data, accelerating discovery and getting more treatments to more patients more quickly.

If you have questions about Tidbits, click here to contact us!

TRANSLATOR TIDBIT 02

Background

NCATS launched the Biomedical Data Translator program to help researchers formulate and refine hypotheses and reduce the time needed to advance discoveries made in the laboratory to clinical application. Ultimately, Translator will accomplish this through an informatics platform that bridges pre-clinical basic research data with clinical data, which will enable exploration of relationships across the full spectrum of data types. Existing biomedical data often remain disconnected, disorganized and mired in disparate jargon from different areas of research. This condition is illustrated below as the “Chasm of Semantic Despair.”

Figure 1: Crossing the Chasm of Semantic Despair. Courtesy of Christopher Chute and Julie McMurry

To address the Chasm of Semantic Despair, Translator aims to link previously disparate sources of molecular, cellular, pharmaceutical, patient and other data to form a more complete and comprehensible picture of existing knowledge.

The Power of Translator

Translator Query

This section will outline the question for Translator to answer.

What is...

Translator strives to answer a broad range of biomedically relevant questions that other systems simply cannot. While existing data sources may contain pieces of the solution individually, Translator leverages information from many sources simultaneously to form a more complete answer at a scale that would not be humanly possible.

If one data source associates A with B and another source associates B with C, Translator will connect A to C through B because it is mining through both sources. Now amplify this across more than 100 sources and the power of Translator becomes clear. Translator will not only allow users to search across many fields of study but also can retrieve relevant information related to the initial query that the user may not have been aware of, providing possible insight or a “Tidbit” that would not otherwise be easily discoverable. Due to the vast number of data sources that could be mined, Translator needs to be built within a collaborative ecosystem to maximize its effectiveness.

What is a Tidbit?

To help prospective users of Translator better understand the variety and complexity of questions it aspires to answer, the consortium developed Tidbits. A Tidbit is a use case that tells a compelling story and demonstrates the unique power of Translator.

Each Tidbit includes:

  • The question that was asked.
  • A description of the answer.
  • Relevant background information.
  • The reasons that Translator’s results or process are unique and valuable in this case.

For additional information, at the end of each Tidbit the reader will find a drop-down box with a more detailed explanation of process details, technical approach and validation. For this Tidbit, the drop-down boxes provide additional insight into Translator as a program.

Timeline of the Translator Program

September 2016

Issued notice of awards

October 2016

First face-to-face meeting

November 2016

Released funds

January 2017

Architecture meeting

May 2017

First Translator hackathon

September 2017

Reasoning tool FOA released

October 2017

Hackathon

January 2018

Reasoning tool initial awards issued

May 2018, Sept. 2018, March 2019, Sept. 2019

Additional hackathons

Process Details

The conceptual map outlined below is a visual representation of planned and existing connections that Translator can make between data types.

Figure 2. This node-edge graph shows the myriad of different types of connections that Translator tools can make between different types of data. Data types (nodes) include chemicals, gene products, patient groups, tissues, genomics, model organisms, conditions and pathways. The details of each connection are not necessarily important, but the graph shows that these disparate data types can be connected together in dozens of ways that can lead to the generation of novel translational hypotheses. Node Graph Legend for Figure 2.
Figure 2: Conceptual map of Translator connections

 

Technical Approach

Teams collaborated throughout the feasibility assessment period to create the knowledge graph standard and the reasoner answer standards. To learn more about existing application programming interfaces (APIs) and semantic standards, please refer to the Smart API Registry and the map in BioThings Explorer.

Data Sources

Translator currently utilizes more than 130 data sources, and that number is growing continuously. It would be impossible for any one person to keep up with all of the different kinds of data available, so it is important that Translator can identify and suggest which data are the most useful to a user’s question without the user directing that process. In each Tidbit, we will explain what data were used to answer the question.

Validation

Translator continually undergoes validation by subject matter experts from many disciplines evaluating the results it produces for both correctness and completeness.

What's Next?

As the program continues to develop and document compelling Tidbits, we hope that you will explore them with us and see what Translator is capable of.

Zero to 60 Drugs in Three Seconds - Finding New Uses for Existing Drugs to Treat Parkinson’s Disease
02

Zero to 60 Drugs in Three Seconds - Finding New Uses for Existing Drugs to Treat Parkinson’s Disease

Utilizing Open Clinical Data to Predict Patient Outcomes
03

Utilizing Open Clinical Data to Predict Patient Outcomes

Finding Marketed Drugs that might Treat an Unknown Syndrome by Perturbing the Disease Mechanism Pathway
04

Finding Marketed Drugs that might Treat an Unknown Syndrome by Perturbing the Disease Mechanism Pathway